Fennec Pharmaceuticals Inc. (TSX: FRX)

Fennec Pharmaceuticals Revenue

Fennec Pharmaceuticals had revenue of $6.97M USD in the quarter ending September 30, 2024, with 7.05% growth. This brings the company's revenue in the last twelve months to $49.35M, up 278.09% year-over-year. In the year 2023, Fennec Pharmaceuticals had annual revenue of $21.25M with 1,284.50% growth.

• Revenue (ttm): $49.35M
• Revenue Growth: +278.09%
• P/S Ratio: n/a
• Revenue / Employee: $1.70M
• Employees: 29
• Market Cap: 236.13M CAD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	21.25M	19.72M	1,284.50%
Dec 31, 2022	1.54M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	170.00K	-	-
Dec 31, 2019	-	-	-